Please login to the form below

Not currently logged in
Email:
Password:

flu

This page shows the latest flu news and features for those working in and with pharma, biotech and healthcare.

Moderna CEO makes case for firm’s lofty valuation

Moderna CEO makes case for firm’s lofty valuation

Vaccines for diseases such as flu are unlikely to turn into big sellers – although Bancel reckons its candidate for cytomegalovirus (CMV) is pitching at a “several billion dollar” market.

Latest news

  • Roche’s new flu pill Xofluza approved in US Roche’s new flu pill Xofluza approved in US

    including those resistant to Roche’s now off-patent and former blockbuster flu treatment, Tamiflu. ... Xofluza significantly reduced the duration of flu symptoms compared to placebo, and demonstrated similar efficacy compared to oseltamivir.

  • Dynavax is ‘deal-ready’ after solid ESMO data; analyst Dynavax is ‘deal-ready’ after solid ESMO data; analyst

    The consistent results, plus a side effect profile for SD-101 that seems fairly benign with the most common reactions mild, flu-like symptoms, means Dynavax is ready to advance the

  • Encouraging data for Roche flu drug ahead of FDA decision Encouraging data for Roche flu drug ahead of FDA decision

    The CAPSTONE-2 trial showed that baloxavir marboxil significantly reduced time in improvement of influenza symptoms versus placebo in people at high risk of serious complications from flu,  which included adults ... If approved, baloxavir marboxil will

  • Pfizer signs mRNA flu vaccine deal with BioNTech Pfizer signs mRNA flu vaccine deal with BioNTech

    Using mRNA is an attractive proposition for flu vaccine development because its can be sued to code for “any protein or multiple proteins, and the potential to manufacture higher potency flu ... vaccines more rapidly and at a lower cost than

  • Roche’s Tamiflu successor hits the mark in complicated flu Roche’s Tamiflu successor hits the mark in complicated flu

    a flu pandemic and despite spirited debate over its efficacy and controversy over access to clinical trials data. ... The drug works by works by inhibiting an enzyme known as cap-dependent endonuclease, which the flu virus relies on to penetrate human

More from news
Approximately 7 fully matching, plus 306 partially matching documents found.

Latest Intelligence

  • The false economy of following the leader The false economy of following the leader

    Pain relief brands settle for being like Nurofen, cold and flu brands settle for being like Lemsip, and the healthcare world keeps turning without disruption.

  • Deal Watch February 2017 Deal Watch February 2017

    The portfolio also includes Buscopan (antispasmodic), Suppositoria Glycerini (laxative) and expectorants for cough and flu, Mucothiol and Mucodyne.

  • A rare talent A rare talent

    The affordability question. Winter, with its flu crises and bed shortages, brings the UK's healthcare spending into sharp relief, but the affordability question facing the NHS isn't a seasonal

  • Pharma deals during April 2014 Pharma deals during April 2014

    Well-known brands include:. •   Pain: Excedrin (Novartis), Beecham's headache powder and Panadol (GSK)  . •   Smoking cessation: Nicorette and Nicoderm (GSK), Nicotinell (Novartis). •   Cold-and-flu: Theraflu and Triaminic (Novartis),

  • ASEAN: Domestic vaccines manufacturers ASEAN: Domestic vaccines manufacturers

    Beyond traditional vaccines, Indonesia's exposure to H5N1 influenza and its resulting contributions to global flu outbreak monitoring have driven further vaccines developments. ... Through a technology transfer from the Biken Institute of Japan, together

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics